]>
IRCT20190731044396N1 IRCT 2019-10-02 Shiraz University of Medical Sciences The effect of vitamin C on flu-like syndrome in MS patient The effect of vitamin C on flu-like syndrome in MS patient after starting beta-interferon 2019-08-23 anticipated 100 Complete https://irct.ir/trial/41783 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Other, Purpose: Supportive, Randomization description: patients were divided into control and case groups using permutation block randomization method with block size equal to 4, randomization list was generated based on Random allocation ratio software, Blinding description: The study is a triple-blind study. Neither the researcher nor the analyzer are aware of the patient being placed in the case or control group. The other person who trained by researcher, gives placebo or Vit C, which are similar in appearance and taste to the main drug (interferon ), and both of them are stored at room temperature. After selecting Vit C and placebo groups, each patient in case group will receive a 250mg Vit C chew-able tablet each night from the Osveh and Patients in control group will receive a placebo-coated tablet similar to the Vit C tablet that are studied by Shiraz Pharmacy School. 3 FLS in MS Pt that receives beta interferon. Intervention 1: Intervention group: administration of daily Vit C (250mg) for 3 months. Intervention 2: Control group: administration of daily placebo tablets for 3 months. Yes - There is a plan to make this available What will be shared: Part of the data is the main consequence of the study When: Start the access period 6 months after printing the results To whom: Researchers working in academia and industry Conditions: Supporting use Where to obtain: Dr. Maryam Poursadegh fard poursadegh@sums.ac.ir How to obtain: After submitting the request and checking the available items,The data is obtained Comments:
public Maryam Poursadeghfard
Karim khane zand Blvd, namazi, motahari clinic
Shiraz Iran (Islamic Republic of) 7134814336 +98 71 3612 1065 Poursadegh@sums.ac.ir Shiraz University of Medical Sciences scientific Maryam Poursadeghfard
Karim khane zand Blvd, namazi, motahari clinic
Shiraz Iran (Islamic Republic of) 7134814336 +98 71 3612 1065 Poursadegh@sums.ac.ir Shiraz University of Medical Sciences Iran (Islamic Republic of) MS patients based on the McDonald's 2017 Criterion, taking interferon for the first time. 20 years no limit Both A patient with MS who has been on the interferon therapy for some time Patients who do not wish to participate in the study. Rehabilitation Placebo Intervention group: administration of daily Vit C (250mg) for 3 months Control group: administration of daily placebo tablets for 3 months Fever and chills, weakness, muscle body pain. Timepoint: first, second and third months. Method of measurement: flu like syndrome symptoms score. Shiraz University of Medical Sciences Approved 2019-07-28 Ethics committee of Shiraz University of Medical Sciences Zand Street, Shiraz University of Medical Sciences Shiraz Fars Iran (Islamic Republic of)